Diamond Biofund Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was TWD 1,437.58 million compared to TWD 2,269.86 million a year ago. Basic loss per share from continuing operations was TWD 1.9153 compared to TWD 3.0254 a year ago. Diluted loss per share from continuing operations was TWD 1.9153 compared to TWD 3.0254 a year ago.
For the six months, net loss was TWD 1,464.62 million compared to net income of TWD 577.1 million a year ago. Basic loss per share from continuing operations was TWD 1.9576 compared to basic earnings per share from continuing operations of TWD 0.7712 a year ago. Diluted loss per share from continuing operations was TWD 1.9576 compared to diluted earnings per share from continuing operations of TWD 0.7458 a year ago.